Humana Inc. HUM recently said that its Medicare Advantage plans have made a sharp comeback in federal quality ratings for 2027. Under the Centers for Medicare and Medicaid Services (CMS) five-star system, 95% of its members are now enrolled in plans rated at least four stars, while 42% are in plans earning 4.5 stars.
The insurer secured six contracts with 4.5 stars and 12 with four stars, bringing its total of highly rated contracts to 18, up 11 from last year. Its standalone prescription drug plan also received 4.5 stars. Humana links this progress to better care coordination, stronger member engagement and wider access to preventive healthcare services across markets.
Medicare's star ratings assess how well insurers deliver care, serve members and support their health. They also shape consumers' choices during annual enrollment, giving Humana a stronger selling point against rivals. Beyond ratings, the results show tangible changes in care: 663,000 more care opportunities were addressed, and another 534,000 members completed annual preventive visits.
Outreach led to 28,000 overdue mammograms, uncovering 600 previously undetected breast cancers. Separately, 93,000 colorectal screenings identified 100 precancerous or cancer cases. These gains suggest Humana is reaching patients earlier, potentially avoiding more serious health problems later while keeping treatment options open.
The improved 2027 Star Ratings are expected to strengthen Humana's quality bonus payment prospects in 2028, potentially supporting revenues and profitability. With more members covered by four-star or better contracts, Humana stands to earn higher bonus payments and retain more funding for plan benefits. That could support pricing, customer retention and margins.
HUM also reaffirmed its 2026 adjusted earnings outlook of at least $9 per share and said some 2028 gains may fund one-time investments and shareholder returns.
HUM’s Price Performance
Humana’s shares have gained 51.1% year to date compared with the 15.3% rise of the industry it belongs to.
Image Source: Zacks Investment Research
Zacks Rank & Stocks to Consider
Humana currently carries a Zacks Rank #3 (Hold).
Enhancing the array of healthcare options, some better promising stocks in the broader Medical sector include Brookdale Senior Living Inc. BKD, UnitedHealth Group Incorporated UNH and Aveanna Healthcare Holdings Inc. AVAH. While Brookdale Senior Living currently sports a Zacks Rank #1 (Strong Buy), UnitedHealth and Aveanna Healthcare carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Brookdale Senior Living’s 2026 bottom line suggests 105.4% year-over-year improvement. BKD has witnessed one upward estimate revision over the past 60 days against no movement in the opposite direction.
The consensus estimate for UnitedHealth’s full-year 2026 earnings indicates a 21.4% year-over-year increase. UNH’s earnings beat estimates in each of the past four quarters, with an average surprise of 12.1%. The consensus mark for 2026 revenues is pegged at $446.78 billion.
The consensus mark for Aveanna Healthcare’s 2026 full-year earnings implies a 36.7% jump from the year-ago reported figure. AVAH’s earnings beat estimates in each of the past four quarters, with an average surprise of 49.3%. The consensus mark for its current-year revenues is pegged at $2.69 billion, which indicates a 10.6% year-over-year increase.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Humana Inc. (HUM): Free Stock Analysis Report
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
Brookdale Senior Living Inc. (BKD): Free Stock Analysis Report
Aveanna Healthcare Holdings Inc. (AVAH): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).